MedPath

Circulating and Urinary Microtranscriptome Reveal MicroRNAs Profile for Predicting Renal Recovery from Severe Acute Kidney Injury

Conditions
Inpatients with acute kidney injury stage III, by definition KDIGO AKI 2012 , admit at King Chulalongkorn Memorial Hospital.
MicroRNAs, Renal recovery, Renal non-recovery, Acute kidney injury
Registration Number
TCTR20210721002
Lead Sponsor
The Kidney Foundation of Thailand, Thailand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Enrolling by invitation
Sex
All
Target Recruitment
120
Inclusion Criteria

The participant must be at age 18 years or above, has Acute kidney injury stage III, according to the definition of KDIGO AKI 2012, and has urine analysis with urine RBC less than 3/HPF, and urine WBC less than 3/HPF.

Exclusion Criteria

- CKD defined as persistent glomerular filtration rate < 60 mL/min/1.73m2
for at least 3 months.
- Pregnancy
- Advanced stage of cancer
- Single kidney
- Previous history of renal replacement therapy within 30 days
- History of renal transplantation

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Discovery of miRNA expressions in urine for predicting renal recovery after acute kidney injury. 2 years NanoString nCounter system assays in dicovery phase and qRT-PCR analysis in validation phase
Secondary Outcome Measures
NameTimeMethod
Discovery of miRNA expressions in blood for predicting renal recovery after acute kidney injury. 2 years NanoString nCounter system assays in dicovery phase and qRT-PCR analysis in validation phase
© Copyright 2025. All Rights Reserved by MedPath